Phase 3 Clinical Trials With Primary Completion Dates in August 2017

This is a list of Phase 3 trials with primary completion dates in August 2017 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker tool. It includes information on all clinical trials for publicly traded companies, screenable by stock symbol, market cap, disease, completion date, and phase.

The primary completion date is the date that the final subject was examined or received an intervention for the purposes of final collection of data for the primary outcome. It provides advance notice that a company will be announcing trial results in the near future.

SymbolCompanyPrimary Completion DatePhaseNCT IDTitle
ADMSAdamas Pharmaceuticals, Inc.2017-08-01Phase 3NCT02202551Open-Label Safety Study of ADS-5102 in PD Patients With LID
ARDXArdelyx, Inc.2017-08-01Phase 3NCT02686138A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
BIVVBioverativ Inc.2017-08-01Phase 3NCT01454739Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A
BIVVBioverativ Inc.2017-08-01Phase 3NCT01425723Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B
CEMPCempra, Inc.2017-08-01Phase 3NCT02210325Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea
CTICCTI BioPharma Corp.2017-08-01Phase 3NCT01321541Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
DBVTDBV Technologies S.A.2017-08-01Phase 3NCT02636699Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
DRRXDURECT Corporation2017-08-01Phase 3NCT02574520Trial of Extended Release Bupivacaine for Pain Relief After Surgery
EGLTEgalet Corporation2017-08-01Phase 3NCT02716857Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain
ENDPEndo International plc2017-08-01Phase 3NCT00356213Comparison of Laparoscopic Sleeve Gastrectomy and Roux-Y-gastric Bypass in the Treatment of Morbid Obesity
KALAKala Pharmaceuticals, Inc.2017-08-01Phase 3NCT02819284Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
KALAKala Pharmaceuticals, Inc.2017-08-01Phase 3NCT02813265Safety and Efficacy of KPI-12 in Subjects With Dry Eye Disease
LIVNLivaNova PLC2017-08-01Phase 3NCT03014180Clinical Evaluation of LEft VEntricular Auto Threshold Alogrithm (LEVEA)
MTFBMotif Bio plc2017-08-01Phase 3NCT02607618Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2
NBRVNabriva Therapeutics plc2017-08-01Phase 3NCT02813694Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia
NDRMNeuroDerm Ltd.2017-08-01Phase 3NCT02782481A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations
NURONeuroMetrix, Inc.2017-08-01Phase 3NCT02809846Quell Opioid Reduction and Pain Relief in Patients With Cancer
ORPNBioblast Pharma Ltd.2017-08-01Phase 3NCT02328482Continuation Protocol to Protocol BBCO-001
RAREUltragenyx Pharmaceutical Inc.2017-08-01Phase 3NCT02537431Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)
VSARVersartis, Inc.2017-08-01Phase 3NCT02339090Versartis Long-Acting Growth Hormone in Children Compared to Daily rhGH
ZGNXZogenix, Inc.2017-08-01Phase 3NCT02926898A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome